Dr. Shankar Siva: combination of immunotherapy and stereotactic ablative radiotherapy may be a better choice for cancer patients

Posted On 2018-12-27 09:20:38

The 10th Shanghai International Conference on Radiation Oncology (SICRO) was held on August 11, 2018 in Shanghai, China. Before the conference, the Editorial Office of Precision Cancer Medicine is honored to make an interview with Dr. Shankar Siva, a Radiation Oncologist and NHMRC fellow at the Peter Mac and leads the Stereotactic Ablative Body Radiotherapy (SABR) program and Australia's first dedicated SABR clinic. This interview is to share his experience among the peer regarding radiotherapy and immunotherapy in cancer treatment.

Read More>>